Malignant Peripheral Nerve Sheath Tumor

12 clinical trials · Condition

Record	Firm	Date
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors (NCT04222413)	National Cancer Institute (NCI)	2020-10-27
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma (NCT04420975)	Jonsson Comprehensive Cancer Center	2020-10-14
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)	National Cancer Institute (NCI)	2017-01-30
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma (NCT02584309)	Washington University School of Medicine	2016-02-22
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery (NCT02180867)	National Cancer Institute (NCI)	2014-08-12
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) (NCT01418001)	Memorial Sloan Kettering Cancer Center	2011-08-01
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931)	Timothy Cripe	2010-03-01
Sorafenib and Dacarbazine in Soft Tissue Sarcoma (NCT00837148)	Memorial Sloan Kettering Cancer Center	2009-02-01
Natural History Study of Patients With Neurofibromatosis Type I (NCT00924196)	National Cancer Institute (NCI)	2008-02-25

Every clearance here is in the API, with alerts when new ones post.